Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors

Bibliographic Details
Main Author: Mathew, A. J.
Publication Date: 2024
Other Authors: Lund, M. L., Pedersen, M. P., Rasmussen, S. H., Glintborg, B., Loft, A. G., Nissen, M. J., Möller, B., Rodrigues, A. M., Santos, F. P., Rotar, Z., Tomšič, M., Relas, H., Peltomaa, R., Gudbjornsson, B., Löve, T. J., Kocaer, S. B., Koken Avsar, A., Midtbøll Ørnbjerg, L., Østergaard, M.
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10362/167903
Summary: Funding Information: The EuroSpA Research Collaboration Network was financially supported by Novartis Pharma AG. Novartis did not influence data collection, statistical analyses, manuscript preparation or decision to submit the manuscript. The outline of was drawn by Mr Rajkumar, Department of Anatomy, Christian Medical College, Vellore, India. Publisher Copyright: © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
id RCAP_647de4d1a57321ad89cc27f5e69cfcf8
oai_identifier_str oai:run.unl.pt:10362/167903
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitorsclinical burden, patient-reported outcomes, and treatment responseRheumatologyImmunology and AllergyImmunologyFunding Information: The EuroSpA Research Collaboration Network was financially supported by Novartis Pharma AG. Novartis did not influence data collection, statistical analyses, manuscript preparation or decision to submit the manuscript. The outline of was drawn by Mr Rajkumar, Department of Anatomy, Christian Medical College, Vellore, India. Publisher Copyright: © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.Objective: To explore the registration of enthesitis among biologic-naïve patients with psoriatic arthritis (PsA) initiating tumour necrosis factor inhibitor (TNFi) treatment across 12 European registries, compare the disease burden and patient-reported outcomes (PROs) between patients with and without enthesitis, and assess the enthesitis treatment response. Method: Demographics, clinical characteristics, and PROs at first TNFi (TNFi-1) initiation (baseline) were assessed in patients with PsA, diagnosed by a rheumatologist, with versus without assessment of entheses and between those with versus without enthesitis. Enthesitis scores and resolution frequency were identified at follow-up. Results: Of 10 547 patients in the European Spondyloarthritis (EuroSpA) Research Collaboration Network initiating TNFi, 1357 underwent evaluation for enthesitis. Eight registries included a validated scoring system for enthesitis. At baseline, 874 patients underwent entheses assessment [Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) 485 patients, Spondyloarthritis Research Consortium of Canada (SPARCC) 389 patients]. Enthesitis was detected by MASES in 170/485 (35%, mean score ± sd 3.1 ± 2.4) and by SPARCC in 236/389 (61%, 4 ± 3.4). Achilles enthesitis was most frequent, by both MASES (unilateral/bilateral 28%/9%) and SPARCC (48%/18%). MASES/SPARCC baseline and follow-up scores for TNFi-1 were available for 100/105 patients. Of these, 63 patients (63%) (MASES) and 46 (43.8%) (SPARCC) achieved resolution of enthesitis. The site-specific enthesitis resolution was overall lower at SPARCC sites (peripheral; 63–80%) than at MASES sites (mainly axial; 82–100%) following TNFi-1. Disease activity and PROs were worse in patients with versus without enthesitis. Conclusion: Entheseal assessments are only registered in a minority of patients with PsA in routine care. When assessed, enthesitis was common, and a substantial proportion demonstrated resolution following treatment with TNFi-1.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNMathew, A. J.Lund, M. L.Pedersen, M. P.Rasmussen, S. H.Glintborg, B.Loft, A. G.Nissen, M. J.Möller, B.Rodrigues, A. M.Santos, F. P.Rotar, Z.Tomšič, M.Relas, H.Peltomaa, R.Gudbjornsson, B.Löve, T. J.Kocaer, S. B.Koken Avsar, A.Midtbøll Ørnbjerg, L.Østergaard, M.2024-05-28T00:33:36Z2024-052024-05-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/167903eng0300-9742PURE: 91985889https://doi.org/10.1080/03009742.2024.2336743info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-24T01:40:01Zoai:run.unl.pt:10362/167903Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T17:54:58.405501Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors
clinical burden, patient-reported outcomes, and treatment response
title Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors
spellingShingle Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors
Mathew, A. J.
Rheumatology
Immunology and Allergy
Immunology
title_short Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors
title_full Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors
title_fullStr Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors
title_full_unstemmed Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors
title_sort Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors
author Mathew, A. J.
author_facet Mathew, A. J.
Lund, M. L.
Pedersen, M. P.
Rasmussen, S. H.
Glintborg, B.
Loft, A. G.
Nissen, M. J.
Möller, B.
Rodrigues, A. M.
Santos, F. P.
Rotar, Z.
Tomšič, M.
Relas, H.
Peltomaa, R.
Gudbjornsson, B.
Löve, T. J.
Kocaer, S. B.
Koken Avsar, A.
Midtbøll Ørnbjerg, L.
Østergaard, M.
author_role author
author2 Lund, M. L.
Pedersen, M. P.
Rasmussen, S. H.
Glintborg, B.
Loft, A. G.
Nissen, M. J.
Möller, B.
Rodrigues, A. M.
Santos, F. P.
Rotar, Z.
Tomšič, M.
Relas, H.
Peltomaa, R.
Gudbjornsson, B.
Löve, T. J.
Kocaer, S. B.
Koken Avsar, A.
Midtbøll Ørnbjerg, L.
Østergaard, M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Mathew, A. J.
Lund, M. L.
Pedersen, M. P.
Rasmussen, S. H.
Glintborg, B.
Loft, A. G.
Nissen, M. J.
Möller, B.
Rodrigues, A. M.
Santos, F. P.
Rotar, Z.
Tomšič, M.
Relas, H.
Peltomaa, R.
Gudbjornsson, B.
Löve, T. J.
Kocaer, S. B.
Koken Avsar, A.
Midtbøll Ørnbjerg, L.
Østergaard, M.
dc.subject.por.fl_str_mv Rheumatology
Immunology and Allergy
Immunology
topic Rheumatology
Immunology and Allergy
Immunology
description Funding Information: The EuroSpA Research Collaboration Network was financially supported by Novartis Pharma AG. Novartis did not influence data collection, statistical analyses, manuscript preparation or decision to submit the manuscript. The outline of was drawn by Mr Rajkumar, Department of Anatomy, Christian Medical College, Vellore, India. Publisher Copyright: © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
publishDate 2024
dc.date.none.fl_str_mv 2024-05-28T00:33:36Z
2024-05
2024-05-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/167903
url http://hdl.handle.net/10362/167903
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0300-9742
PURE: 91985889
https://doi.org/10.1080/03009742.2024.2336743
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833597055777374208